Staged Kidney Transplantation During Combined Heart/Kidney Transplantation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCedars-Sinai Medical Center
About this trial
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
Eligibility criteria
Qualifiers
Adult patients (18 years or older) undergoing combined heart and kidney transplantation at Cedars-Sinai Medical Center.
Disqualifiers
Patients who undergo simultaneous heart/kidney transplantation in a single operative event due to medical necessity will be excluded.
Patients with medical records flagged as "break-the-glass" or "research opt-out" within the center's electronic health record.
Trial design
Treatments tested in this trial
- Planned delayed implantation of kidney allograft with ex vivo machine perfusion kidney preservation.
Treatment groups
20 Participants
are divided into 1 treatment groupLocations
1Cedars-Sinai Medical Center90048, Los AngelesCalifornia, United States
Sponsors and collaborators
Cedars-Sinai Medical Center
Lead sponsor
Source ClinicalTrials.gov